{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifzfkzizea5puazfbb7qpg35x3age6lchkhntzxdvdf6i27hkjjda",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkculgbta2o2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieprflrfbsz6m5n2o3wucmslpqnmstrqv7p7r5d6bvu2kmcvv6ut4"
    },
    "mimeType": "image/jpeg",
    "size": 72060
  },
  "path": "/2026/04/24/sanofi-ms-drug-europe-reveiew-regeneron-white-house/?utm_campaign=rss",
  "publishedAt": "2026-04-24T13:19:52.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "drug pricing",
    "Pharmaceuticals",
    "research"
  ],
  "textContent": "A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.",
  "title": "STAT+: Sanofi MS drug gets positive review in Europe following FDA",
  "updatedAt": "2026-04-24T13:19:57.000Z"
}